Escalon Medical ESMC
OTC ESMC
$0.17 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Escalon Medical (ESMC) Gains from Sales and Divestitures (2013 - 2026)

Updated

Escalon Medical (ESMC) posted Gains from Sales and Divestitures of $2.81 million for fiscal Q3 2026 (quarter ended Mar 31, 2026).

Analysis

Escalon Medical (ESMC) Gains from Sales and Divestitures (2013 - 2026) Analysis & Trends

For FY2018 (ended Jun 30, 2018), Escalon Medical's Gains from Sales and Divestitures came in at $500,000.

  • Annual Gains from Sales and Divestitures shows a five-year compound annual growth rate of -28.7% (FY2013 to FY2018).
  • The fiscal Q3 2026 figure stands as the lowest quarterly Gains from Sales and Divestitures since fiscal Q3 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.93 Bn 230.96 Bn 4.88 Bn
2 Abbott Laboratories 181.29 Bn 151.72 Bn 7.27 Bn
3 Danaher 158.18 Bn 141.99 Bn 3.61 Bn
4 Intuitive Surgical 153.47 Bn 132.89 Bn 1.96 Bn
5 Medtronic 118.97 Bn 84.22 Bn 6.34 Bn
6 Stryker 114.72 Bn 100.84 Bn 4.50 Bn
7 Boston Scientific 66.18 Bn 60.95 Bn 3.85 Bn
8 Becton Dickinson 52.49 Bn 49.64 Bn 2.32 Bn
9 Edwards Lifesciences 50.32 Bn 34.33 Bn 1.35 Bn
10 Escalon Medical 1.36 Mn -3.48 Mn 946,662.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.81 Mn
Mar 31, 2013 2.72 Mn
API Access

Escalon Medical Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ESMC&period=max&api_key=YOUR_API_KEY